Express Pharma - Express Pharma

Sustained-release implant Duravyu may reduce treatment burden in wet AMD patients while maintaining efficacy and durability

Gland Pharma secures 180-day exclusivity for Angiotensin II Acetate Injection following USFDA approval

TRIgnite-1 study shows 79 per cent response rate and no dose-limiting toxicities in early-stage trial of BCMA × CD38 × CD3…

SCD-044 trials for psoriasis and atopic dermatitis show no major safety concerns

Company also signs licensing deal for exclusive rights to immuno-oncology therapies Botensilimab and Balstilimab in India and Sri…

Seed-stage deals dominate as funding surges over fivefold from April, led by PB Healthcare’s $156 million round

DST’s Technology Development Board extends financial support to Nagpur-based Nitika for manufacturing 14 advanced excipients under…

Indoco Remedies UK begins distribution of cardiovascular treatment via Clarity Pharma across the United Kingdom

Dr Adatia to support Oliver Wyman’s healthcare and investor-focused strategy in India with cross-sector experience and digital…

Nair to take charge from July 1, 2025; joins Cipla’s senior management with focus on global manufacturing and compliance